Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Amoxicillin and Cephalexin PK/PD in the NICU
NCT04916951Phase 1Completed
- Sponsor
- University of Colorado Denver
- Start
- Jul 2021
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of amoxicillin and cefalexin in neonatal infection (4 arms), sponsored by University of Colorado Denver. Primary endpoint: Time above Minimum Inhibitory Concentration at 24 hours. Started Jul 2021; status: completed.
02
Drugs
amoxicillincefalexin
03
Conditions
neonatal infection
Beyond the preview
Go deeper on NCT04916951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04916951.